Tirzepatide
Prescription medicationGLP-1 medication · also: mounjaro, zepbound
An FDA-approved prescription dual GIP/GLP-1 medicine (brands Mounjaro, Zepbound) — a medication, not a supplement.
People commonly track it for
Tracked as a prescription medicine (approved for type 2 diabetes, chronic weight management, and obstructive sleep apnea in obesity) alongside a person's supplements.
Evidence summary
FDA-approved with established indications. Compounded or online 'versions' are not reviewed by the FDA the same way.
Regulation & source status
FDA-approved, prescription-only. The label carries a Boxed Warning tied to a thyroid-tumor finding in animal studies and is contraindicated with a personal/family history of medullary thyroid cancer or MEN 2 — a clinician determines eligibility.
Route considerations
A subcutaneous injection used as prescribed. If you self-inject, safe sharps disposal is worth reviewing with a pharmacist.
Storage considerations
A cold-chain product — follow the label and your pharmacist's storage guidance; don't use an injectable that arrived warm.
Interaction & context review
The label notes it slows gastric emptying and specifically addresses oral hormonal contraceptives; timing of oral medicines is a clinician/pharmacist question. Don't change a prescription based on a tracker.
Sport / duty status
Not on the WADA Prohibited List as of the 2026 list.
Track this item
Log it as a medication-context item and export a clean list for your clinician. StackWise doesn't provide dosing or timing rules.
Track this itemPeptide safety & source review
Sources
- MedlinePlus — Tirzepatide injection
- DailyMed — Mounjaro prescribing information
- FDA — Concerns with unapproved GLP-1 drugs used for weight loss
Source reviewed: 2026-07-23.